Search for Articles
Feb 20, 2024
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease
Feb 1, 2024
Basking Biosciences Announces Close of $55 Million Financing to Accelerate Clinical Development for First Reversible Thrombolytic for Ischemic Stroke
Jan 25, 2024
CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study
Jan 17, 2024
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Dec 13, 2023